Extracorporeal Membrane Oxygenation Machine Market Analysis

Type (Veno-Venous, Veno-Arterial, Arterio-Venous)

The veno-arterial segment in the extracorporeal membrane oxygenation machine market is estimated to gain the largest revenue share of 60% in the year 2037. Veno arterial (VA) extracorporeal membrane oxygenation machine is an integral part of heart transplantation protocols since it provides vital support to the patient during the critical period between organ harvesting and implantation.

This use of VA ECMO extends the viability of donor hearts by ensuring optimal conditions for successful transplantation. Nearly 0.1 million patients are hospitalized due to cardiogenic shock in the U.S. every year and VA ECMO is the most widely used by cardiologists for complete and immediate support for cardiac arrest.

The growth of the market in this segment is driven by its integral role in addressing cardiac emergencies, and seamlessly integrating into heart transplantation protocols.

End Users (Hospitals, Specialty Clinics, Emergency Medical Services)

The hospital segment is expected to garner a significant share in the year 2037. Government initiatives that are enhancing critical care infrastructure in hospitals are contributing to the growth of extracorporeal membrane oxygenation machine utilization.

Additionally, the increased funding for the expansion and refurbishment of critical care units is enabling hospitals to invest in innovative life support technologies, including ECMO machine. The government allocates critical care infrastructure, signifying the prioritization of resources for advanced technologies like these in hospitals.

Overall, the hospital segment in the market is thriving due to the increasing extensiveness of critical cases and rising utilization for pediatric cases.

Our in-depth analysis of the global market includes the following segments: